Delivery Order SPE2DB20D7061-SPE2DB25FSMZ9
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg vials of the drug Infliximab. The total ceiling value of the contract is $4,837.61, and it has an ultimate completion date of July 25, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen is the prime contractor for this award, which is part of a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,345,957 units of INFLIXIMAB 100 MG VIALS, a specialty medication. The contract has a ceiling value of $9,473.15 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,699.90 firm fixed-price delivery order is for the supply of 4,568,061,467 vials of the medication Infliximab 100 mg. The contract has an ultimate completion date of April 29, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA...
The Defense Logistics Agency (DLA) awarded a $10,017.36 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,835,720 units of Infliximab 100 mg vials. The contract has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery...
This is a delivery order under a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $999,999,999, is an Indefinite Delivery Contract (IDC) that provides a range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order, valued at $4,789.29, is for the supply of 100 mg vials of the drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Remicade (infliximab) 100 mg vials. The contract has a ceiling value of $5,582.95 and a period of performance through July 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,024.40, is for the supply of 4,568,093,049 units of Remicade 100 mg vials. The award has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award, with an ID of SPE2DX15D3012|SPE2DX24F8TZ6, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of 4565551648 units of Infliximab 100 mg vials. The contract is a Firm Fixed Price Delivery Order, valued at $20,020.97, with a performance period ending on August 23, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is providing these critical medical supplies to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $23,954.18 and covers the delivery of Remicade 100 mg vials. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $15,624.47 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to supply 100 mg vials of the biologic drug infliximab. Performance will take place in Conshohocken, Pennsylvania over one day in July 2023. No additional details were provided regarding the original solicitation or whether this contract utilizes an existing indefinite delivery/indefinite quantity...